Zobrazeno 1 - 10
of 11
pro vyhledávání: '"L Gambitta"'
Publikováno v:
Section 4: Clinical pharmacy services.
Background and importance The 3 monthly formulation of paliperidone palmitate (3MPP) was introduced to the Italian market in 2017 for the treatment of schizophrenia in adult patients. 3MPP is a useful treatment option for patients who are adequately
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f4e22f7871f36599d666d5fb5f719d39
https://doi.org/10.1136/ejhpharm-2021-eahpconf.176
https://doi.org/10.1136/ejhpharm-2021-eahpconf.176
Publikováno v:
Section 5: Patient Safety and Quality assurance.
Background and importance Central venous catheters, peripherally inserted central catheters, Port-a-cath and Midline are fundamental systems to manage acute and chronic treatments in both inpatients and outpatients. Available dressings must provide a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::df0b7b52fd8f7fd656c9728fdb002915
https://doi.org/10.1136/ejhpharm-2020-eahpconf.405
https://doi.org/10.1136/ejhpharm-2020-eahpconf.405
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background and importance In Italy, antimicrobial resistance is among the highest in Europe. The ECDC 2017 surveillance report confirmed a high percentage of critical bacterial isolates with disturbing antimicrobial resistance characteristics, accord
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7781d78269d77b42bd9d776a01f2d312
https://doi.org/10.1136/ejhpharm-2020-eahpconf.133
https://doi.org/10.1136/ejhpharm-2020-eahpconf.133
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background Guanidinoacetate methyltransferase (GAMT) deficiency is a rare disorder (prevalence Purpose The objective was to report our experience, in order to focus on the importance of galenic preparations, unique resources to treat paediatric patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::83af802326c0112f764d02d9c9eb2458
https://doi.org/10.1136/ejhpharm-2019-eahpconf.337
https://doi.org/10.1136/ejhpharm-2019-eahpconf.337
Publikováno v:
Section 5: Patient Safety and Quality Assurance.
Background Alectinib is indicated as a second-line treatment of adult patients with advanced non-small cell lung cancer (NSCLC) anaplastic lymphoma kinase (ALK) positive, previously treated with crizotinib. Clinical safety data do not report adverse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a888b45216253a0456ece681de892b33
https://doi.org/10.1136/ejhpharm-2019-eahpconf.498
https://doi.org/10.1136/ejhpharm-2019-eahpconf.498
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background Pressure ulcers (PUs) are a complex problem that affects many patients in every hospital ward. The main goal of healthcare providers is to treat patients’ major diseases, leading often to an underestimation of PUs. Thanks to a multidisci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b47a0d829b1bac4e7cc5f68667fa3e2a
https://doi.org/10.1136/ejhpharm-2019-eahpconf.357
https://doi.org/10.1136/ejhpharm-2019-eahpconf.357
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background The anti-microbial resistance (AMR) situation in Italy is worse than in many other EU Member States. The latest EARS-Net 2015 report confirms a high percentage of invasive bacterial isolates with disturbing AMR characteristics, significant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3cc9d6a6fd4b06e79b6c8c9e5219f5e9
https://doi.org/10.1136/ejhpharm-2019-eahpconf.201
https://doi.org/10.1136/ejhpharm-2019-eahpconf.201
Publikováno v:
Eur J Hosp Pharm
Background ADHD is a clinical condition that can break out in childhood and can persist until adulthood. It has been demonstrated that ADHD in adulthood affects quality of life, in particular social and professional relationships. Although internatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a35cf1b77907a6413e704d86147dc81a
https://europepmc.org/articles/PMC7535835/
https://europepmc.org/articles/PMC7535835/
Publikováno v:
Eur J Hosp Pharm
Background To insert a drug into the Hospital Pharmaceutical Formulary (HPF) it is necessary to carry out a drug-economic analysis. The health economics study offers analysis tools such as Net Monetary Benefit (NMB) and Incremental Cost-Effectiveness
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bf512f86fae2911630f8cbfa1d60b92
https://doi.org/10.1136/ejhpharm-2018-eahpconf.399
https://doi.org/10.1136/ejhpharm-2018-eahpconf.399
Publikováno v:
Patient safety and risk management.
Background Ifosfamide is an alkylating agent effective in young patients affected by sarcoma. Its use is limited due to severe side effects: haemorrhagic cystitis, prevented with mesna; neurotoxicity is currently its worse adverse effect. Hepatic con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d642988cf5da4f298c4cefae375a8a5e
https://doi.org/10.1136/ejhpharm-2017-000640.539
https://doi.org/10.1136/ejhpharm-2017-000640.539